21 May 2013
Interviewee/Contributer: Bruno Pagliara
Organisation: On-kòs Pharma Consulting
Full text available to subscribers only. Click here for information on subscribing to MedNous.
Interviewee/Contributer: Rolf Günther
Organisation: Affimed Therapeutics AG
Monday May 6 2013